Know Cancer

or
forgot password

    • cancer clinical trials in kansas city, KS

    • Double Cord Versus Haploidentical (Blood and Marrow Transplant Clinical Trials Network #1101)
    University of Kansas Hospital
    Kansas City, Kansas 66160
    Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma, Follicular Lymphoma, Hodgkin Lymphoma, Mantle Cell Lymphoma
    VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
    LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib
    University of Kansas Cancer Center DeptofUofKansas CancerCenter-2
    Kansas City, Kansas 66160
    Non-Small Cell Lung Cancer
    Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Surgery
    Providence Medical Center
    Kansas City, Kansas 66112
    Childhood Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer, Type 1 Papillary Renal Cell Carcinoma, Type 2 Papillary Renal Cell Carcinoma
    Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    High Risk Acute Myeloid Leukemia
    Weight Loss and Maintenance for Individuals With Intellectual Developmental Disabilities (IDD)
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Weight Loss
    Safety and Efficacy of CML Patients Who Switch to Nilotinib and Stop Treatment After Achieving and Sustaining MR4.5.
    University of Kansas Cancer Center Clinical Research Center
    Kansas City, Kansas 66160
    CML
    Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Prostate Cancer
    Phase 3 Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Muscular Dystrophy, Duchenne, Muscular Dystrophies, Muscular Disorders, Atrophic, Muscular Diseases, Musculoskeletal Diseases, Neuromuscular Diseases, Nervous System Diseases, Genetic Diseases, X-Linked, Genetic Diseases, Inborn
    Evaluation of Intravenous Ascorbic Acid
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Safety and Pharmacokinetics of Intravenous Ascorbate
    Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Brain and Central Nervous System Tumors
    Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Breast Cancer
    SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
    SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Leukemia, Neutropenia, Thrombocytopenia
    Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Leukemia
    Topotecan in Treating Children With Refractory Leukemia
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Leukemia
    SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Head and Neck Cancer
    Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Chronic Myeloproliferative Disorders, Infection, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Leukemia
    SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
    Veterans Affairs Medical Center - Kansas City
    Kansas City, Kansas 64128
    Melanoma (Skin)
    Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Head and Neck Cancer
    SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Breast Cancer, Cardiac Toxicity
    Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Leukemia
    S9630, Medroxyprogesterone in Treating Women With Breast Cancer
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Breast Cancer, Endometrial Cancer
    S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Adrenocortical Carcinoma
    Combination Chemotherapy in Treating Children With Progressive Brain Tumors
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Brain and Central Nervous System Tumors
    S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Lung Cancer
    Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Endometrial Cancer
    S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Pancreatic Cancer
    Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Melanoma (Skin)
    Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Cardiac Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Breast Cancer
    S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Endometrial Cancer
    S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Lung Cancer
    Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Pancreatic Cancer
    SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Head and Neck Cancer
    SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Colorectal Cancer
    Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Breast Cancer
    S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Cervical Cancer
    Irofulven in Treating Children With Recurrent or Refractory Solid Tumors
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Women With Breast Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Breast Cancer
    506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Leukemia, Lymphoma
    S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Neuroendocrine Carcinoma of the Skin
    Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Brain and Central Nervous System Tumors
    S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Lung Cancer
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Colorectal Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Anal Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Brain and Central Nervous System Tumors
    Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
    Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Ovarian Cancer
    S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
    University of Kansas Medical Center
    Kansas City, Kansas 66160-7353
    Malignant Mesothelioma
    Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
    Kansas Cancer Institute at the University of Kansas Medical Center
    Kansas City, Kansas 66160-7357
    Leukemia